We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Magnolia's Peterson Holds 975,746 Pure Cycle Shares

Magnolia Capital Fund, LP, The Magnolia Group, LLC, and Adam K. Peterson filed a Schedule 13G Amendment No. 3 with the SEC on November 10, 2026, disclosing their beneficial ownership of common stock in Pure Cycle Corporation as of September 30, 2026.

Anjali Anand | 10 November 2026

State Street Discloses 5% Stake in L3Harris Technologies

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of approximately 5% of the common stock of L3Harris Technologies Inc. as of September 30, 2026.

Nitish Kishor | 10 November 2026

State Street Discloses 4.4% Stake in Lexeo Therapeutics

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, reporting beneficial ownership of common stock in Lexeo Therapeutics Inc. as of September 30, 2026.

Nitish Kishor | 10 November 2026

State Street Reports 2% Stake in Lightbridge Corp

State Street Corporation and SSGA Funds Management, Inc. filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership positions in Lightbridge Corp as of September 30, 2026.

Vinay Lochav | 10 November 2026

State Street Reports 4.7% Stake in MannKind Corp

State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 15,096,712 shares of MannKind Corporation common stock as of September 30, 2026.

Aditi Sarkar | 10 November 2026

State Street Reports 7.7% Stake in Materion Corp

State Street Corporation and its subsidiary SSGA Funds Management, Inc. filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership positions in Materion Corp common stock as of September 30, 2026.

Aakashdeep | 10 November 2026

Evogene Shareholders Approve Cooperation Agreement, Seat Seven-Member Board

Evogene Ltd. filed a Report of Foreign Private Issuer on November 10, 2026, disclosing the results of a special general meeting at which shareholders approved three proposals, including a Cooperation Agreement with L.I.A. Pure Capital Ltd. and Invest-Pro Shukai Hon Ltd., and confirmed the …

Manish Choudhary | 10 November 2026

Intelligent Bio Solutions Q1 FY2027 Revenue Rises to $1.39M

Intelligent Bio Solutions Inc. filed its quarterly report on Form 10-Q for the three months ended September 30, 2026, with the SEC on November 10, 2026, reporting a net loss of $2,658,302 attributable to the company alongside a year-over-year increase in revenue.

Shwetambri Chauhan | 10 November 2026

Ocugen Licenses OCU400 to Celairis for Asia-Pacific

Ocugen, Inc. filed a current report on November 10, 2026, disclosing that it entered into an Exclusive License Agreement with Celairis Therapeutics Holdings Pty Ltd for the commercialization of OCU400 in eight Asia-Pacific countries.

Aditi Sarkar | 10 November 2026

EquipmentShare Q3 2026: 216M Class A Shares Outstanding

EquipmentShare.com Inc (NASDAQ:EQPT) filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 10, 2026, disclosing share counts, filer status, and financial statements for the three and nine months ended September 30, 2026.

Nitish Kishor | 10 November 2026
Support

Hi! How can we help you today?

Loading…